𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Advances in the management of psoriasis: monoclonal antibody therapies

✍ Scribed by Don Mehrabi; Joshua B. DiCarlo; Seaver L. Soon; Calvin O. McCall


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
157 KB
Volume
41
Category
Article
ISSN
0011-9059

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Psoriasis is a common skin disorder characterized by erythematous, scaling plaques. Until recently, therapies for this disease have been aimed at reducing keratinocyte proliferation. We have learned that psoriasis is not primarily a disorder of keratinocyte hyperproliferation, but is an inflammatory disease. This knowledge, especially our current understanding of the role of activated T cells in psoriasis, has led to new therapeutic options and new areas of research. Immunosuppressive agents such as cyclosporine have proven very useful in the treatment of psoriasis, but their use is limited by toxicity. Monoclonal antibodies directed against key components of the inflammatory process have been studied in an attempt to produce safer, more selective immunosuppressive agents. This review summarizes much of the available literature describing the use of monoclonal antibodies in the treatment of psoriasis.


πŸ“œ SIMILAR VOLUMES


Monoclonal antibodies in the study and t
✍ Dana C Matthews; Franklin O Smith; Irwin D Bernstein πŸ“‚ Article πŸ“… 1992 πŸ› Elsevier Science 🌐 English βš– 904 KB

Recent advances utilizing monoclonal antibodies to phenotype acute leukemias have revealed no prognostic significance of the expression of lymphoid-associated antigens by acute myeloid leukemia blasts and conflicting results regarding 'biphenotypic' acute myeloid leukemia. Several studies treating p

Advances in the management of gynecologi
✍ Luther W. Brady πŸ“‚ Article πŸ“… 1975 πŸ› John Wiley and Sons 🌐 English βš– 675 KB

Much progress has been made in the utilization of radiation therapy techniques in the management of gynecologic malignancies. However, new techniques will continue to emerge for the management of these disease processes. At this time, high LET radiation is particularly exciting, as are the potential

Current applications of monoclonal antib
✍ David A. Scheinberg πŸ“‚ Article πŸ“… 1991 πŸ› Elsevier Science 🌐 English βš– 803 KB

Recent trials of monoclonal antibodies in patients with leukemias or lymphomas have demonstrated the remarkable potency of these agents to kill tumor cells specifically and safely. New molecular biological and radiochemical techniques are also allowing rapid inroads into the remaining obstacles to t